Disease & disorder

chikungunya

MONDO:0017941

An infection that is caused by the Chikungunya virus, which is transmitted by mosquitoes; it is characterized by fever and severe arthralgia.

Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms9

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Chikungunya

Chikungunya is an infection caused by the chikungunya virus. The most common symptoms are fever and joint pain, typically occurring four to eight days after the bite of an infected mosquito. The pain has been described as "excruciating"; however some people may be infected without showing any symptoms. Other symptoms may include headache, muscle pain, joint swelling, and a rash. Symptoms usually improve within a week; however, occasionally the joint pain may last for months or years. The very young, old, and those with other health problems are at risk of more severe disease. The virus is spread between people by two species of mosquito in the genus Aedes: Aedes albopictus and Aedes aegypti, which mainly bite during the day, particularly around dawn and in the late afternoon. The virus may circulate within a number of animals, including birds and rodents. Diagnosis is done by testing the blood for either viral RNA or antibodies to the virus. The symptoms can be mistaken for those of dengue fever and Zika fever, which are spread by the same mosquitoes. It is believed most people become immune after a single infection. The best means of prevention are overall mosquito control and the avoidance of bites in areas where the disease is common. This may be partly achieved by decreasing mosquitoes' access to water, as well as the use of insect repellent and mosquito nets. Chikungunya vaccines have been approved for use in the United States and in the European Union. No specific treatment for chikungunya is available. The chikungunya virus is widespread in tropical and subtropica...

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.